Lynch Syndrome Screening and Surveillance Trends among Gastroenterologists in Japan: A Questionnaire Survey-based Analysis.

Lynch syndrome microsatellite instability testing mismatch repair genetic testing questionnaire survey universal tumor screening

Journal

Internal medicine (Tokyo, Japan)
ISSN: 1349-7235
Titre abrégé: Intern Med
Pays: Japan
ID NLM: 9204241

Informations de publication

Date de publication:
25 Oct 2024
Historique:
medline: 28 10 2024
pubmed: 28 10 2024
entrez: 27 10 2024
Statut: aheadofprint

Résumé

Objective Screening and surveillance methodologies for Lynch syndrome (LS) in Japan. This study assessed the changes in LS knowledge and practice trends. Methods In 2020 and 2022, 2 questionnaire surveys were administered to 3574 councilors of the Japanese Society of Gastroenterology to assess changes in LS-related knowledge and practices. Patients or Materials Each questionnaire item was analyzed by comparing responses between the first and second surveys to determine the proportion of doctors selecting each option relative to the total number of respondents. The responses from doctors who completed both surveys were analyzed to assess the temporal changes in their responses. Results The second survey showed a significant increase in the awareness of universal tumor screening (UTS), proportion of doctors selecting UTS for primary LS screening, use of BRAF V600E testing for chemotherapy selection, and number of newly diagnosed LS patients per doctor over the last three years. In addition, the number of patients currently under surveillance by doctors has also increased. Doctors who intensified primary screening for LS between surveys reported a greater increase in newly diagnosed cases. However, the rise in UTS suggests a potential bias from doctors with heightened interest in LS, which may have influenced the findings. Conclusion The number of newly diagnosed and currently monitored patients with LS in Japan has been increasing, likely due to expanded screening practices. However, the potential bias introduced by the increased adoption of UTS should be considered when interpreting these results.

Identifiants

pubmed: 39462590
doi: 10.2169/internalmedicine.4471-24
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Yuji Urabe (Y)

Department of Gastroenterology, Hiroshima University Hospital, Japan.

Shiro Oka (S)

Department of Gastroenterology, Hiroshima University Hospital, Japan.

Hideki Ishikawa (H)

Department of Molecular-Targeting Prevention, Kyoto Prefectural University of Medicine, Japan.

Takeshi Nakajima (T)

Medical Ethics and Medical Genetics, School of Public Health, Kyoto University, Japan.

Kohji Tanakaya (K)

Department of Surgery, National Hospital Organization Iwakuni Clinical Center, Japan.

Tetsuji Takayama (T)

Department of Gastroenterology and Oncology, Tokushima University Graduate School of Biomedical Science, Japan.

Hideyuki Ishida (H)

Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Japan.

Shinji Tanaka (S)

JA Onomichi General Hospital, Japan.

Classifications MeSH